Brief: Proqr Therapeutics NV Reports Q1 Loss Per Share EUR 0.25
May 6 (Reuters) - ProQR Therapeutics NV PRQR.O :
* Q1 LOSS PER SHARE EUR 0.25
* AT MARCH 31, 2021, PROQR HELD CASH AND CASH EQUIVALENTS OF
EUR
67.9 MILLION, COMPARED TO EUR 75.8 MILLION AT DECEMBER 31, 2020
* Q1 EARNINGS PER SHARE VIEW EUR -0.25 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNEbC1H7y
Further company coverage: PRQR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview